Holding On To Marriott Hotels As 2025 Recession Risk Paints Mixed Picture — Neutral
MAR Seeking Alpha — March 25, 2025Marriott International gets its prior hotel rating from 2023 reaffirmed again, agreeing with the Seeking Alpha quant system rating but more cautious than analysts. The company is a leader among global hotel companies, with a diversified brand portfolio, and a rooms growth pipeline that could benefit from positive macro demand forecasts. Although having a strong profit margin in its sector, it is lagging in cashflow growth and also is very indebted with a negative equity.

Barclays promotes Schulte to co-head global investment grade syndicate — Neutral
BCS Reuters — March 25, 2025Barclays has named Scott Schulte global co-head of its investment grade syndicate, whose U.S. unit he had headed since October 2023, an internal memo showed.

Tevogen Bio Appoints David E. Banko as Global Head of Government Affairs and Patient Access, Advances Commercialization Plan — Neutral
TVGN GlobeNewsWire — March 25, 2025WARREN, N.J., March 25, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech company leveraging AI-driven immunotherapy drug discovery, today announced the appointment of David E. Banko, CPA, a leading expert with three decades of industry experience in market access and health policy, to its leadership team as Global Head of Government Affairs and Patient Access.

WBA DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Walgreens Boots Alliance, Inc. Investors to Secure Counsel Before Important March 31 Deadline in Securities Class Action - WBA — Neutral
WBA GlobeNewsWire — March 25, 2025NEW YORK, March 25, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Walgreens Boots Alliance, Inc. (NASDAQ: WBA) between April 2, 2020 and January 16, 2025, both dates inclusive (the “Class Period”), of the important March 31, 2025 lead plaintiff deadline.

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages The Bancorp, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – TBBK — Neutral
TBBK GlobeNewsWire — March 25, 2025NEW YORK, March 25, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of The Bancorp, Inc. (NASDAQ: TBBK) between January 25, 2024 and March 4, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 16, 2025.

ERIC & OneLayer Unveil New Solution for Private Cellular Networks — Positive
ERIC Zacks Investment Research — March 25, 2025Ericsson collaborates with OneLayer to introduce a Zero Touch Zero Trust Network Access solution to upgrade the latter's network against evolving threats.

What Makes Hanover Insurance Group (THG) a Strong Momentum Stock: Buy Now? — Positive
THG Zacks Investment Research — March 25, 2025Does Hanover Insurance Group (THG) have what it takes to be a top stock pick for momentum investors? Let's find out.

InterDigital (IDCC) Is Up 0.12% in One Week: What You Should Know — Positive
IDCC Zacks Investment Research — March 25, 2025Does InterDigital (IDCC) have what it takes to be a top stock pick for momentum investors? Let's find out.

Are You Looking for a Top Momentum Pick? Why Embraer (ERJ) is a Great Choice — Positive
ERJ Zacks Investment Research — March 25, 2025Does Embraer (ERJ) have what it takes to be a top stock pick for momentum investors? Let's find out.

Horizon Bancorp (HBNC) Moves to Strong Buy: Rationale Behind the Upgrade — Positive
HBNC Zacks Investment Research — March 25, 2025Horizon Bancorp (HBNC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Simmons First National (SFNC) Moves to Buy: Rationale Behind the Upgrade — Positive
SFNC Zacks Investment Research — March 25, 2025Simmons First National (SFNC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

EPR Properties (EPR) Upgraded to Buy: What Does It Mean for the Stock? — Positive
EPR Zacks Investment Research — March 25, 2025EPR Properties (EPR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

The AZEK Company (AZEK) Upgraded to Buy: What Does It Mean for the Stock? — Positive
AZEK Zacks Investment Research — March 25, 2025The AZEK Company (AZEK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

APTIV HLDS LTD (APTV) Upgraded to Buy: Here's Why — Positive
APTV Zacks Investment Research — March 25, 2025APTIV HLDS LTD (APTV) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

First Merchants (FRME) Upgraded to Strong Buy: Here's Why — Positive
FRME Zacks Investment Research — March 25, 2025First Merchants (FRME) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Northeast Community Bancorp (NECB) Upgraded to Buy: Here's Why — Positive
NECB Zacks Investment Research — March 25, 2025Northeast Community Bancorp (NECB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

All You Need to Know About Great Southern Bancorp (GSBC) Rating Upgrade to Buy — Positive
GSBC Zacks Investment Research — March 25, 2025Great Southern Bancorp (GSBC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Century Therapeutics (IPSC) Upgraded to Buy: What Does It Mean for the Stock? — Positive
IPSC Zacks Investment Research — March 25, 2025Century Therapeutics (IPSC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Creative Medical Technology Holdings, Inc. (CELZ) Upgraded to Buy: What Does It Mean for the Stock? — Positive
CELZ Zacks Investment Research — March 25, 2025Creative Medical Technology Holdings, Inc. (CELZ) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Rocket Lab USA, Inc. (RKLB) Shareholders — Neutral
RKLB Accesswire — March 25, 2025NEW YORK, NY / ACCESS Newswire / March 25, 2025 / If you suffered a loss on your Rocket Lab USA, Inc. (NASDAQ:RKLB) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rocket-lab-usa-inc-lawsuit-submission-form?prid=138599&wire=1 or contact Joseph E. Levi, Esq.
